On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Ophthalmology and Eye Disorders

TopicLeading institutions, researchers & key papers

Ophthalmology and Eye Disorders is a topic indexed in ScholarIQ from OpenAlex.

What is known about Ophthalmology and Eye Disorders?

ScholarIQrecord summary

This cluster of papers focuses on the pathophysiology, management, and associated conditions of Graves' ophthalmopathy, including the role of thyroid-associated ophthalmopathy, orbital fibroblasts, thyrotropin receptor antibodies, teprotumumab treatment, autoimmune mechanisms, thalamus infarction, surgical interventions for strabismus, and the involvement of the IGF-1 receptor. The research covers a wide range of topics related to the understanding and treatment of Graves' ophthalmopathy.

How many works does Ophthalmology and Eye Disorders have?

ScholarIQindexed works

Ophthalmology and Eye Disorders has 163 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Ophthalmology and Eye Disorders?

ScholarIQopenalex

The OpenAlex for Ophthalmology and Eye Disorders is on the source record.

What are the most-cited papers on Ophthalmology and Eye Disorders?

ScholarIQmost cited works
Teprotumumab for Thyroid-Associated Ophthalmopathy
Terry J. Smith, George J. Kahaly, Daniel G. Ezra, James C. Fleming, Roger A. Dailey, Rosa A. Tang, Gerald J. Harris, Alessandro Antonelli, Mario Salvi, Robert A. Goldberg, James W. Gigantelli, Steven M. Couch, Erin M. Shriver, Brent Hayek, Eric M. Hink, Richard M. Woodward, Kathleen Gabriel, Guido Magni, Raymond S. Douglas
New England Journal of Medicine. 2017733 CitationsOPEN ACCESS
Randomized Controlled Trial of Rituximab in Patients With Graves' Orbitopathy
Marius N. Stan, James A. Garrity, Barbara Gisella Carranza Leon, Thapa Prabin, Elizabeth A. Bradley, Rebecca S. Bahn
The Journal of Clinical Endocrinology & Metabolism. 2014358 CitationsOPEN ACCESS
New insights into the pathogenesis and nonsurgical management of Graves orbitopathy
Peter Taylor, Lei Zhang, Richard Lee, Ilaria Muller, Daniel G. Ezra, Colin Dayan, George J. Kahaly, Marian Ludgate
Nature Reviews Endocrinology. 2019315 CitationsOPEN ACCESS
Risk Factors for Development or Deterioration of Graves' Ophthalmopathy
Marius N. Stan, Rebecca S. Bahn
Thyroid. 2010230 CitationsOPEN ACCESS
Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial
George J. Kahaly, Michaela Riedl, J. König, Susanne Pitz, Katharina A. Ponto, Tanja Diana, Elena Kampmann, E. W. Kolbe, Anja Eckstein, Lars C. Moeller, Dagmar Führer, Mario Salvi, Nicola Currò, Irene Campi, Danila Covelli, Marenza Leo, Michele Marinò, Francesca Menconi, Claudio Marcocci, Luigi Bartalena, Petros Perros, Wilmar M. Wiersinga, Göksün Ayvaz, Lelio Baldeschi, Kostas Boborides, Antonella Boschi, Thomas Heiberg Brix, Lucy Clarke, Colin Dayan, Chantal Daumerie, A. Jane Dickinson, N. Fichter, László Hegedüs, Onur Konuk, Gerassimos Krassas, Carol Lane, John H. Lazarus, Dan S Morris, Maarten P. Mourits, Marco Nardi, C Neoh, Jacques Orgiazzi, Simon H. S. Pearce, Georg von Arx, Miloš Žarković
The Lancet Diabetes & Endocrinology. 2018219 Citations

Where is Ophthalmology and Eye Disorders research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Ophthalmology and Eye Disorders is open access?

ScholarIQopen access share
73%OPEN ACCESS
Gold
13%
Green
33%
Hybrid
0%
Bronze
27%
Closed
27%

Related on ScholarIQ

470M+ articles · 14-day free trial